Form 4: Axogen Director William P. Burke Reports Stock Vesting

Director William P. Burke reported the vesting of 11,904 restricted stock units of Axogen, Inc. on September 1, 2024.

Summary

• William P. Burke, a director of Axogen, Inc., reported a transaction on September 1, 2024.
• The transaction involved the vesting of 11,904 restricted stock units, each representing a contingent right to receive one share of Axogen common stock.
• These restricted stock units vested as part of an annual equity grant for service as a Director on the Axogen, Inc. Board of Directors.
• The grant was valued at $150,000 as of the grant date and vested on September 1, 2024, the one-year anniversary of the grant date.
• Following the transaction, Burke directly owns 28,557 shares of Axogen common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The vesting of stock units can be seen as a positive sign of alignment between management and shareholders.

Positives

• The vesting of restricted stock units aligns the director's interests with those of the shareholders.
• The equity grant serves as compensation for Burke's service as a director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices for board members.

Stakeholder Impact

• The vesting of stock units aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates